Sign In
Buy URGN
$38.24
-2.85 (-6.94%)
At Close: Jul 31, 2026
SAN FRANCISCO, June 06, 2025 (GLOBE NEWSWIRE) -- A securities class action lawsuit styled Cockrell v. UroGen Pharma Ltd.
Levi & Korsinsky Notifies UroGen Pharma Ltd. (URGN) Shareholders of Class Action Lawsuit And July 28, 2025 Deadline
04:30pm, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
Levi & Korsinsky Notifies UroGen Pharma Ltd. (URGN) Investors - Lead Plaintiff Deadline on July 28, 2025
04:00pm, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain
Investors in UroGen Pharma Ltd. (URGN): Protect Your Rights - Contact Levi & Korsinsky Before July 28, 2025
12:15pm, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
UroGen Pharma Ltd. (URGN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
12:00pm, Friday, 06'th Jun 2025
LOS ANGELES , June 6, 2025 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to UroGen Pharma Ltd.
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN). Such
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of UroGen
10:38am, Friday, 06'th Jun 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In UroGen To Contact Him Directly To Discuss Their Options
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of UroGen Phar
URGN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against UroGen Pharma Ltd. - July 28, 2025 Deadline
09:00am, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK, June 06, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ: URGN) and certain of the
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
08:00am, Friday, 06'th Jun 2025
PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, tod
UroGen Pharma Ltd. (URGN) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of July 28, 2025 Deadline
07:30am, Friday, 06'th Jun 2025
NEW YORK, NY / ACCESS Newswire / June 6, 2025 / If you suffered a loss on your UroGen Pharma Ltd. (NASDAQ:URGN) investment and want to learn about a potential recovery under the federal securities law
NEW YORK CITY, NY / ACCESS Newswire / June 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against UroGen
Shareholders that lost money on UroGen Pharma Ltd.(URGN) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
05:45am, Friday, 06'th Jun 2025
NEW YORK , June 6, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in UroGen Pharma Ltd. ("UroGen Pharma Ltd.
